Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21100174 | 1.00 | NPSR1 (0.32) | NPSR1TP53POLB | |
| SCHEMBL26382546 | 1.00 | NPSR1 (0.32) | NPSR1TP53POLB | |
| SCHEMBL21100159 | 0.85 | MAPT (0.33) | POLB | |
| SCHEMBL800709 | 0.85 | — | — | |
| SCHEMBL13197315 | 0.85 | MAPT (0.33) | POLB | |
| SCHEMBL21099805 | 0.85 | MAPT (0.33) | POLB | |
| SCHEMBL22548934 | 0.84 | — | — | |
| SCHEMBL256670 | 0.83 | — | — | |
| SCHEMBL25080919 | 0.82 | CHRM2 (0.31) | — | |
| SCHEMBL21099775 | 0.82 | CHRM2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
| US-20200354425-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | DONG-A ST CO., LTD. (KR) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354425-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | GLP1R, GIPR, GPR119 | NPSR1 195/4885TP53 4679/4885POLB 4739/4885 |
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | NPSR1 195/4885TP53 4679/4885POLB 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.